CellsBin Expands into New Branford Headquarters
Following its initial launch in New Haven, CellsBin has expanded into additional manufacturing space on Business Park Drive in Branford and recently secured Series A funding to scale production, broaden its clinical footprint, and accelerate commercialization in partnership with leading academic and medical centers, including Yale University.
CellsBin is pioneering rare-cell biology, with initial applications focused on cancer immunotherapy. The company’s platform enables therapy development and clinical monitoring by measuring therapeutic cell persistence, functional efficacy, and tumor response without the need for invasive biopsies. Following its initial launch in New Haven, CellsBin has expanded into additional manufacturing space on Business Park Drive in Branford and recently secured Series A funding to scale production, broaden its clinical footprint, and accelerate commercialization in partnership with leading academic and medical centers, including Yale University. AdvanceCT has worked with CellsBin since its inception and has supported the company throughout its current phase of expansion by facilitating connections with CCAT and exploring fundraising opportunities. As CellsBin continues its rapid growth, the company plans to add 6 new jobs across its New Haven and Branford operations, and we look forward to continuing our collaboration in the years ahead.
Read more: https://www.advancect.org/media/userfiles/subsite_190/files/reports/Annual%20Report%202025.pdf